EUVIMEDEUVIMED entdecken
Open Access

Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer

Wanjun Lu, Lixia Liu, Xiang Kang, Kangkang Ren, Ye Huang, Minzhang Cheng, Xiaolei Li, Fei Xu, Xinping Xu

Acta Biochimica et Biophysica Sinica · 2024

DOI: 10.3724/abbs.2024069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2024. Verfasst von Wanjun Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Clinical Research Center for Respiratory Diseases, Jiangxi Institute of Respiratory Disease, Department of Respiratory and Critical Care Medi…. Hauptthemen laut MEDLINE: Cetuximab, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug Synergism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CetuximabCarcinoma, Non-Small-Cell LungLung NeoplasmsDrug SynergismMice, NudeXenograft Model Antitumor AssaysHumansAnimalsCell Line, TumorMiceErbB ReceptorsCell ProliferationAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred BALB CHSP90 Heat-Shock ProteinsApoptosisAntineoplastic Agents

Stichwörter der Autor:innen

STA9090cetuximabnon-small cell lung cancerreceptor tyrosine kinasesynergistic effect

Substanzen

CetuximabErbB ReceptorsHSP90 Heat-Shock ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Jiangxi Clinical Research Center for Respiratory Diseases, Jiangxi Institute of Respiratory Disease, Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Jiangxi Medical College, Nanchang…
  • The First Clinical Medical College, Nanchang University, Nanchang 30006, China.
  • Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.
  • Jiangxi Hospital of China-Japan Friendship Hospital, Nanchang 330052, China.

Zitieren

APA

Lu, W., Liu, L., Kang, X., Ren, K., Huang, Y., Cheng, M., Li, X., Xu, F., & Xu, X. (2024). Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024069

Vancouver

Lu W, Liu L, Kang X, Ren K, Huang Y, Cheng M, et al. Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2024069

BibTeX
@article{Lu2024,
  author = {Lu, Wanjun and Liu, Lixia and Kang, Xiang and Ren, Kangkang and Huang, Ye and Cheng, Minzhang and Li, Xiaolei and Xu, Fei and Xu, Xinping},
  title = {Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2024},
  doi = {10.3724/abbs.2024069}
}
Kostenlos starten →